Lizhi
Back to libraryEntry · LZH-005
GHRH analog · GHRH analog

Tesamorelin

Stabilized growth hormone releasing hormone analog

Technical datasheetLZH-005
Code
GHRH analog
Half-life
~26-38 min (SC)
Research route
Subcutaneous (research)
Molecular targets
GHRH receptor (pituitary)
Discovery / disclosure
Theratechnologies, approved 2010
Target purity
≥ 98%
Recommended storage
−20°C, light protected. 2 to 8°C after reconstitution.
Aliases
TH9507, Egrifta
Appearance
White lyophilized powder
Solubility
Soluble in aqueous buffer, dilute acetic acid
Sequence
[trans-3-hexenoyl]-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL
Analysts reviewing the HPLC chromatogram for the current batch
FIG. 201Analytical Lab

Identity, purity and main-peak area are checked by reversed-phase HPLC against an in-house reference standard for this sequence. The chromatogram you see on the certificate of analysis is generated at this exact bench, by the analysts who release the batch.

Technician monitoring a stainless steel reactor during scale-up
FIG. 202Scale-up Operations

When a sequence moves from milligram research lots to multi-gram research supply, the same chemistry is transferred onto jacketed stainless reactors. Temperature, agitation and reagent equivalents are logged in real time so that the larger batch matches the analytical fingerprint of the small one.

01

Overview

Tesamorelin is a 44 amino acid stabilized GHRH analog, with an N-terminal trans-3-hexenoyl group that improves plasma stability.

02

Pharmacology and mechanism

Selectively acts on pituitary GHRH receptors, driving pulsatile growth hormone secretion and restoring physiological GH and IGF-1 axis rhythms.

03

Research areas

R.01
Stabilized growth hormone releasing hormone analog

Studied in visceral adipose deposition, HIV-associated lipodystrophy and cognitive or aging-related GH axis changes.

04

Structural notes

44 amino acid sequence with an N-terminal 3-hexenoyl modification, sharing high homology with native hGHRH.

Sequence
[trans-3-hexenoyl]-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL
For research use only. Not medical advice. Not for diagnosis or treatment.